Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Mesoblast.
RELATED STOCKHEAD STORIES
Health & Biotech
COVID-19 treatments are a better bet than a vaccine
Experts
ScoPo’s health powerplays: Ramp ups and turnaround favs
News
Rise and Shine: What you need to know before the ASX opens
News
Going Viral: All the news about COVID-19 from the week
Health & Biotech
Health: Mesoblast pushes ahead to the next stage of testing for stem cell COVID-19 treatment
Health & Biotech
Dr Boreham’s Crucible: Paradigm’s ‘ballsy’ move that landed it $35m after an FDA knock-back
Health & Biotech
Going viral: All the biggest COVID-19 news from the last week
Health & Biotech
Alex Waislitz-backed Mesoblast is seeing if stem cells can help with COVID-19
Tech
Tech will bounce back faster than ‘older’ sectors, says Alex Waislitz
Health & Biotech
Dr Boreham’s Crucible: The small cap biotechs trying to make a buck from coronavirus
Health & Biotech
